Chaperone therapy for mucopolysaccharidosis type IIIC

被引：1
|
作者：
Pshezhetsky, Alexey V. [1 ]
Pan, Xuefang [1 ]
Heon-Roberts, Rachel [1 ]
Li, Shao-Gang [2 ]
Wu, Harry Y. [1 ]
Taherzadeh, Mahsa [1 ]
De Aragao, Camila De Britto Para [1 ]
Wood, Jill [3 ]
Ekins, Sean [3 ]
Boyd, Robert [3 ]
Freundlich, Joel S. [2 ]
机构：
[1] Univ Montreal, CHU Ste Justine, Montreal, PQ, Canada
[2] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA
[3] Phoenix Nest Inc, New York, NY USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2018年 / 123卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2017.12.329
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
320
引用
收藏
页码：S121 / S122
页数：2
相关论文
共 50 条
  • [21] The First Korean Case of Mucopolysaccharidosis IIIC (Sanfilippo Syndrome Type C) Confirmed by Biochemical and Molecular Investigation
    Huh, Hee Jae
    Seo, Ja Young
    Cho, Sung Yoon
    Ki, Chang-Seok
    Lee, Soo-Youn
    Kim, Jong-Won
    Park, Hyung-Doo
    Jin, Dong-Kyu
    ANNALS OF LABORATORY MEDICINE, 2013, 33 (01) : 75 - 79
  • [22] Correction of Neurological Manifestations of Mucopolysaccharidosis IIIC by a Novel Rationally Designed Neurotropic AAV Gene Therapy Vector
    O'Leary, Claire
    Antunes, Andre
    Tordo, Julie
    Liao, Ai Yin
    Gleitz, Helene
    Parker, Helen
    Holley, Rebecca
    Youshani, Amir Saam
    Stacey, Kevin
    Davis, Daniel
    Dridi, Larbi
    Martins, Carla
    Pshezhetsky, Alexey
    Linden, Michael
    Henckaerts, Els
    Bigger, Brian
    MOLECULAR THERAPY, 2017, 25 (05) : 244 - 244
  • [23] NOVEL VARIANTS IDENTIFIED IN TWO SIBLINGS WITH MUCOPOLYSACCHARIDOSIS TYPE IIIC: THE ROLE OF FUNCTIONAL STUDIES IN CONFIRMING PATHOGENICITY
    Moore, Christine
    Frigeni, Marta
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (03) : 75 - 75
  • [24] Lentiviral gene therapy for mucopolysaccharidosis type IVA
    Celik, Betul
    Rintz, Estera
    Nidhi, Fnu
    Khan, Shaukat
    Tomatsu, Shunji
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 23 - 24
  • [25] Development of an adeno-associated viral vector for mucopolysaccharidosis IIIC
    O'Leary, Claire
    Antunes, Andre
    Parker, Helen
    Henckaerts, Els
    Linden, Michael
    Wilkinson, Fiona
    Pshezhetsky, Alexey
    Bigger, Brian
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S88 - S88
  • [26] The potential of gene therapy for mucopolysaccharidosis type I
    Pimentel Vera, Luisa Natalia
    Baldo, Guilherme
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (01): : 33 - 41
  • [27] Gene therapy for murine mucopolysaccharidosis type VII
    Sands, MS
    Wolfe, JH
    Birkenmeier, EH
    Barker, JE
    Vogler, C
    Sly, WS
    Okuyama, T
    Freeman, B
    Nicholes, A
    Muzyczka, N
    Chang, PL
    Axelrod, HR
    NEUROMUSCULAR DISORDERS, 1997, 7 (05) : 352 - 360
  • [28] Enzyme replacement therapy for mucopolysaccharidosis type IIID
    Chou, Tsui-Fen
    Moen, Derek
    Sauni, Chelsee
    Kan, Shih-hsin
    Wang, Feng
    Zhang, Xiaoyi
    Le, Steven
    Wood, Jill
    Ekins, Sean
    Dickson, Patricia I.
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S39 - S39
  • [29] Localisation of a gene for mucopolysaccharidosis IIIC to the pericentromeric region of chromosome 8
    Ausseil, J
    Loredo-Osti, JC
    Verner, A
    Darmond-Zwaig, C
    Maire, I
    Poorthuis, B
    van Diggelen, OP
    Hudson, TJ
    Fujiwara, TM
    Morgan, K
    Pshezhetsky, AV
    JOURNAL OF MEDICAL GENETICS, 2004, 41 (12) : 941 - 944
  • [30] Enzyme replacement therapy in mucopolysaccharidosis type I
    Miebach, E
    ACTA PAEDIATRICA, 2005, 94 : 58 - 60
12345